Quality Improvement for Cancer Screening Outcomes
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to enhance how doctors and their teams adhere to cancer screening guidelines in primary care settings. Researchers are testing a new method, the Quality Improvement Practice Facilitation Intervention, to help healthcare providers implement these guidelines more effectively. This approach could lead to earlier cancer detection and improved prevention. Individuals who are generally healthy and interested in improving cancer screening practices may be well-suited for this trial. As an unphased trial, it offers participants the chance to contribute to advancing cancer screening practices in healthcare.
Do I need to stop taking my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this practice facilitation intervention is safe for improving cancer screening outcomes?
Research shows that practice facilitation, a method to help healthcare providers improve their work, is very safe. Studies have demonstrated that this approach increases cancer screening rates in primary care settings. Importantly, these studies have not reported any harmful effects from practice facilitation itself.
This method helps doctors and staff follow cancer screening guidelines more effectively. By focusing on improving processes rather than introducing a new drug or treatment, it is generally well-tolerated. Previous research has not found any negative effects related to this facilitation method.12345Why are researchers excited about this trial?
Researchers are excited about the Quality Improvement Practice Facilitation Intervention because it focuses on enhancing the processes behind cancer screening rather than introducing a new drug or therapy. Unlike traditional treatments that directly target cancer, this approach aims to improve how healthcare providers deliver cancer screening services. By optimizing screening workflows and ensuring more consistent follow-ups, the intervention hopes to catch cancers earlier and improve patient outcomes. This method could lead to more efficient screenings and potentially higher survival rates by promoting early detection.
What evidence suggests that this practice facilitation intervention is effective for improving cancer screening outcomes?
Research has shown that the Quality Improvement Practice Facilitation Intervention, which participants in this trial will receive, can effectively boost cancer screening rates in primary care settings. One study aimed to increase breast, cervical, and colorectal cancer screenings by collaborating with healthcare providers and offering expert guidance, achieving positive results in clinics serving low-income communities. This approach helps clinics improve their processes and adhere more closely to cancer screening guidelines. By assisting clinics in better organizing and managing their screening programs, the intervention ensures more patients receive screenings. This method has proven to enhance cancer prevention and early detection efforts.12367
Who Is on the Research Team?
Pamela C Hull, PhD
Principal Investigator
University of Kentucky
Are You a Good Fit for This Trial?
This clinical trial is open to normal volunteers who are interested in participating. There are no specific exclusion criteria, meaning that the study is quite inclusive and anyone willing can potentially join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Practice facilitation intervention for healthcare providers and staff to improve cancer prevention and screening guideline implementation
Follow-up
Participants are monitored for the effectiveness of the intervention in improving cancer screening rates
What Are the Treatments Tested in This Trial?
Interventions
- Quality Improvement Practice Facilitation Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Kentucky
Lead Sponsor
National Cancer Institute (NCI)
Collaborator